Macrocyclic compound
Grant
US12577258B2
Kind: B2
Mar 17, 2026
Assignee
VERNALIS (R&D) LIMITED
Inventors
Takahiko Ito, Misato Takashima, Masakazu Atobe, Koichiro Arai, Tomohisa Toyama, Yu Yoshii, Andrew John Potter, Daniel Paul Maddox, Stuart Ray, Nicolas Foloppe
Abstract
A compound represented by the general formula (1) or a salt thereof, which has a superior IRAK-4 inhibitory activity, and is useful as active ingredients of medicaments for prophylactic treatment and/or therapeutic treatment of diseases relating to IRAK-4 inhibition.
CPC Classifications
C07D 471/18
C07D 498/18
Filing Date
2020-09-30
Application No.
18028578
Claims
19